N/A
Completed N=41
CGM Use in Children With Type 2 Diabetes
Type 2 Diabetes · Hyperglycemia Due to Type 2 Diabetes Mellitus
Source: ClinicalTrials.gov NCT04721158 ↗
Enrolled (actual)
41
Serious AEs
4.9%
Results posted
Aug 2023
Primary outcomePrimary: Percentage of Time in Range Glucose Control — 49.2; 50.7 percentage of time in target range
Summary
The purpose of this prospective study is to determine if trial use of a Dexcom G6 CGM system for a 10 day wear period in pediatric Type 2 diabetes patients improves short term time in range glucose control and 3-6 month glycemic control.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Percentage of Time in Range Glucose Control |
49.2; 50.7 | — |
| PRIMARY Hemoglobin A1c |
10.2; 10.3 | — |
| PRIMARY More Frequent Insulin Administration |
14; 8; 2 | — |
| PRIMARY More Frequent Glycemic Control Monitoring |
23; 0; 1 | — |
Eligibility Criteria
Inclusion Criteria
- Type 2 diabetes, diabetes duration >3 months
Exclusion Criteria
- Prior use of CGM
Data sourced from ClinicalTrials.gov (NCT04721158). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.